Rate Video

ICML 2019 | Hodgkin lymphoma management: Europe vs. USA

Anna Sureda • 19 Jun 2019

Hodgkin Lymphoma Lymphoma

Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, explains the differences in the approach to the management on Hodgkin lymphoma in Europe vs. the USA. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Stem cell therapies promising for Hodgkin lymphoma

Anna Sureda • 14 Jun 2018

Highlights from the 3rd European CAR T-cell Meeting

Anna Sureda • 9 Feb 2021

Transplant & CAR T-cell therapy: what to look forward to at EBMT 2020

Anna Sureda • 30 Jan 2020

The future of lymphoma treatment – combining new therapies with molecular diagnosis

Anna Sureda • 2 Dec 2016

Related Videos

Obstacles faced by women in hem-onc

Loretta Nastoupil • 4 Mar 2021

Women in Lymphoma

Loretta Nastoupil • 4 Mar 2021

Infusion of CD30 CAR T-cells following AuHCT in patients with lymphoma

Marcie Riches • 15 Feb 2021

First-line axicabtagene ciloleucel in lymphoma

Yago Nieto • 15 Feb 2021